Business Wire

Veracode Research Highlights Financial Sector’s Escalating Security Debt

Share

Veracode, a global leader in application risk management, today released new research that highlights the state of software security debt within the financial services sector. Security debt, defined for this report as flaws that remain unfixed for longer than a year, exists in 76 percent of organizations in the financial services sector, with 50 percent of organizations carrying critical security debt.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241029540325/en/

Figure 1: Prevalence of security debt in the financial sector (Graphic: Business Wire)

With the average cost of a data breach in the financial industry estimated to be $6.08 million1, the research comes at a critical time for one of the most highly targeted industries by sophisticated threat actors. According to a U.S. Treasury Department report in March 2024, threat actors use AI-based tools to find and exploit software vulnerabilities at an unprecedented rate. At the same time, increasing industry competition and customer expectations for convenience require organizations to accelerate innovation.

“The high rate of security debt in the financial sector poses significant risks to organizations and their customers if not addressed quickly. As AI-driven cyber-attacks continue to grow in strength and numbers, and organizations struggle to keep up with evolving regulations due to existing security debt, the current landscape allows threat actors to exploit vulnerabilities at an alarming, unprecedented rate,” said Chris Wysopal, Chief Security Evangelist at Veracode. “Our latest State of Software research highlights the critical need for financial institutions to address both first-party and third-party code vulnerabilities now. Organizations that leave flaws unremedied for longer than a year are exposed to prolonged and dangerous threats.”

Delayed Flaw Remediation Threatens Financial Sector Security

Veracode researchers found 40 percent of all applications in the financial sector have security debt, which is slightly better than the cross-industry average of 42 percent. In addition, just 5.5 percent of financial sector applications are flaw-free, compared to 5.9 percent across other industries. While slightly fewer financial sector applications have security debt, they accumulate more of it.

The report also highlights the need for financial services organizations to address security debt in both first-party and third-party code. Eighty-four percent of all security debt affects first-party code, but the majority (78.6 percent) of critical security debt comes from third-party dependencies. This reinforces the importance of the Cybersecurity and Infrastructure Security Agency’s efforts to help secure the open-source ecosystem with its Open Source Software Security Roadmap and Secure by Design Pledge.

The analysis further explores remediation timelines in the financial services sector. Researchers found that financial organizations fix half of first-party flaws in the first nine months, compared to 13 months for third-party flaws. Of those, 52 percent of third-party flaws turn into security debt, while 44 percent of first-party flaws turn into security debt.

The Importance of Prioritization in Risk Remediation

The proliferation of supply chain attacks targeting the financial services industry has brought about a growing number of cybersecurity regulations with a sharper focus on software security. For example, regulatory frameworks like the ISO 20022, the Payment Card Industry Data Security Standard (PCI DSS), NIS2, and the Digital Operational Resilience Act (DORA) require organizations to prevent vulnerabilities from being deployed in applications.

This puts organizations at risk of non-compliance because of existing security debt and outdated remediation strategies. Veracode’s research reveals that organizations can address this risk by prioritizing the 3.3% of flaws that constitute critical security debt. Remediating the most dangerous flaws first means financial entities can then move on to tackle other critical flaws or non-critical debt according to their risk tolerance and capabilities.

The Role of Application Security Posture Management

The increased need for risk prioritization creates a significant demand for Application Security Posture Management (ASPM) to continuously track risk through the collection, visibility and analysis of security issues across the software development cycle. Veracode's Application Risk Management Platform provides a comprehensive, unified view of risk across code and applications, empowering developers and security teams to remediate issues swiftly. With the AI-powered solution, Veracode Fix, teams can proactively prevent new vulnerabilities and effectively reduce existing security backlogs. The platform’s contextual analysis uncovers root causes, guiding developers toward optimal next steps that maximize risk reduction with minimal effort.

Wysopal closed, “It has never been more important for the financial services sector to stay ahead of evolving cybersecurity threats, particularly with increasingly sophisticated AI-driven attacks threatening the security of their assets. I urge financial institutions to prioritize timely security debt reduction by adopting AI-powered remediation and ASPM tools which can detect, prioritize and fix vulnerabilities within seconds.”

The Veracode State of Software Security Financial Services 2024 report is available to read on the Veracode website.

1 IBM, “Cost of a Data Breach Report 2024”, IBM and Ponemon Institute, July 30, 2024

About the State of Software Security Report
The Veracode State of Software Security 2024 report analyzed data from large and small companies, commercial software suppliers, software outsourcers, and open-source projects. The research draws from more than a million (1,007,133) applications across all scan types, 1,553,022 dynamic analysis scans, and 11,429,365 static analysis scans. All those scans produced 96 million raw static findings, 4 million raw dynamic findings, and 12.2 million raw software composition analysis findings.

About Veracode
Veracode is a global leader in Application Risk Management for the AI era. Powered by trillions of lines of code scans and a proprietary AI-assisted remediation engine, the Veracode platform is trusted by organizations worldwide to build and maintain secure software from code creation to cloud deployment. Thousands of the world’s leading development and security teams use Veracode every second of every day to get accurate, actionable visibility of exploitable risk, achieve real-time vulnerability remediation, and reduce their security debt at scale. Veracode is a multi-award-winning company offering capabilities to secure the entire software development life cycle, including Veracode Fix, Static Analysis, Dynamic Analysis, Software Composition Analysis, Container Security, Application Security Posture Management, and Penetration Testing.

Learn more at www.veracode.com, on the Veracode blog, and on LinkedIn and X.

Copyright © 2024 Veracode, Inc. All rights reserved. Veracode is a registered trademark of Veracode, Inc. in the United States and may be registered in certain other jurisdictions. All other product names, brands or logos belong to their respective holders. All other trademarks cited herein are property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241029540325/en/

Contacts

For more information, please contact:
Katy Gwilliam
kgwilliam@veracode.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press Release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press Release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press Release

Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release

Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of

Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye